Centerra Gold (CG) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
Generated nearly $100 million in free cash flow in Q3 2025, driven by strong operational performance at Öksüt and elevated metal prices.
Gold and copper production reached 81,773 oz and 13.4 million lbs, respectively, with gold production costs at $1,346/oz.
Cash balance increased to $562 million, supporting fully funded growth projects and $32 million returned to shareholders via buybacks and dividends.
Advanced key projects: Mount Milligan PFS published, Goldfield development progressed, and Kemess PEA expected in Q1 2026.
Board Chair transition announced: Paul Wright to succeed Michael Parrett effective January 1, 2026.
Financial highlights
Q3 2025 net earnings were $292.2 million, including a $193.5 million non-cash impairment reversal at Goldfield; adjusted net earnings were $66.4 million ($0.33/share).
Q3 sales: 80,598 oz gold and 13.4 million lbs copper; average realized gold price $3,178/oz, copper $3.73/lb.
Consolidated all-in sustaining costs (AISC) on a byproduct basis: $1,652/oz in Q3.
Cash flow from operations: $162 million; free cash flow: $98.7 million.
Adjusted EBITDA increased 50% to $145.8 million; margin improved to 36.9%.
Outlook and guidance
2025 consolidated guidance: 250–290k oz gold, 50–60M lbs copper, AISC on a by-product basis: $1,650–$1,750/oz.
Mount Milligan 2025 production guidance: 145,000–165,000 oz gold, 50–60M lbs copper, with costs near the low end of guidance.
Öksüt 2025 production guidance: 105,000–125,000 oz gold, costs near the low end of guidance.
Thompson Creek Restart on track, first production expected in H2 2027; Goldfield first production targeted by end of 2028.
Capital expenditures for 2025 guided at $105–$130 million, with sustaining capex at $90–$110 million.
Latest events from Centerra Gold
- 2025 exceeded production and financial targets, advancing growth and delivering record returns.CG
Q4 202520 Feb 2026 - Strong balance sheet and discounted valuation support organic growth in gold, copper, and molybdenum.CG
Investor presentation20 Feb 2026 - Q2 2024 saw strong results, robust liquidity, and ongoing capital returns with steady guidance.CG
Q2 20242 Feb 2026 - Restart and ramp-up of US molybdenum assets target $472M NPV8% and 22% IRR by 2028.CG
Investor Update20 Jan 2026 - Strong Q3 cash flow, stable costs, and strategic project progress support 2024 targets.CG
Q3 202417 Jan 2026 - 2024 delivered robust cash flow; 2025 to focus on disciplined spending and project growth.CG
Q4 202421 Dec 2025 - All director nominees, auditor appointment, and executive compensation motions were approved.CG
AGM 202525 Nov 2025 - Q1 2025 saw strong cash flow, robust liquidity, and major project advances.CG
Q1 202524 Nov 2025 - Strong Q2 results, robust liquidity, and project advances offset by higher cost guidance.CG
Q2 202523 Nov 2025